$18.60 Million in Sales Expected for Keryx Biopharmaceuticals (KERX) This Quarter


Wall Street brokerages predict that Keryx Biopharmaceuticals will post sales of $18.60 million for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for Keryx Biopharmaceuticals' earnings, with the lowest sales estimate coming in at $16.90 million and the highest estimate coming in at $21.98 million.



from Biotech News